Bank Of Montreal Ultragenyx Pharmaceutical Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bank Of Montreal holds 6,137 shares of RARE stock, worth $334,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,137

Holding current value

$334,036

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $229,646 - $316,730	6,137 New	6,137 $252,000
Q2 2023 Aug 02, 2023	BUY	$37.35 - $52.15 $177,001 - $247,138	4,739 New	4,739 $218,000
Q1 2023 Jun 13, 2024	BUY	$36.99 - $48.71 $2.01 Million - $2.65 Million	54,407 New	54,407 $2.18 Million
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $4.45 Million - $7.36 Million	111,336 New	111,336 $4.79 Million
Q2 2022 Aug 11, 2022	SELL	$45.8 - $85.4 $1.85 Million - $3.44 Million	-40,319 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$62.2 - $84.4 $464,571 - $630,383	7,469 Added 22.74%	40,319 $2.93 Million
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $30,147 - $35,934	-409 Reduced 1.23%	32,850 $2.8 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $40,518 - $53,248	520 Added 1.59%	33,259 $2.89 Million
Q2 2021 Aug 12, 2021	BUY	$92.19 - $115.71 $3.02 Million - $3.79 Million	32,739 New	32,739 $3.16 Million

Others Institutions Holding RARE

# of Institutions

287

Shares Held

88.1M

Call Options Held

505K

Put Options Held

198K

Vanguard Group Inc Valley Forge, PA

9.78M
Shares

$532 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$305 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.35M
Shares

$291 Million
0.68% of portfolio
Wellington Management Group LLP Boston, MA

4.56M
Shares

$248 Million
0.03% of portfolio
Rtw Investments, LP New York, NY

3.26M
Shares

$177 Million
2.24% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.81B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account